Israel Innovation Authority

RepAir specializes in large-scale carbon removal technology. Its fully electric, zero-heat process efficiently separates CO2 from air using minimal energy, producing no hazardous waste or liquids.

Brain.space is a data company focused on brain mapping, aiming to support researchers, medical professionals, and software developers in interpreting and analyzing brain activity. The company offers a comprehensive and affordable technology stack that includes noninvasive brain activity mapping and monitoring, along with validated big data interpretation and insights. This platform enables users to develop innovative products and services that leverage brain activity data, facilitating advancements in various fields related to neuroscience and mental health.

nT-Tao is building a compact fusion reactor that will generate 10-20 MW of electricity. The reactor is highly scalable and will be about the size of a shipping container, ensuring clean fusion energy wherever needed. The reactor’s scalability and affordability will make it suitable for various power needs, ranging from industrial and manufacturing facilities to small towns and off-grid locations. This scalability coupled with the ability for rapid deployment, positions nT-Tao’s reactor as a versatile and adaptable fusion energy solution. nT-Tao’s unique solution relies on a proprietary plasma heating method which is expected to reach 1000 times higher density than other fusion reactors, thereby making its fusion reaction 1 million times more effective. nT-Tao’s ability for quick development iterations and its groundbreaking approach, dramatically reduces the size, cost, and complexity of fusion energy reactors. Co-founded by Oded Gour-Lavie, Doron Weinfeld, and Boaz Weinfeld, nT-Tao’s mission is to develop a unique nuclear fusion technology that will enable the world to transition towards a cleaner, decarbonized, sustainable, and advanced future.

IBI-Ag is a biotechnology company developing bioinsecticides using environmentally friendly technology. It focuses on discovering and developing selective, safe, and cost-effective biological solutions to control insects and increase crop production worldwide.

Promise Bio is a biotechnology company specializing in precision medicine for autoimmune diseases. It leverages epiproteomic analysis, a cutting-edge technique that examines protein modifications, using a cloud-based AI platform to interpret standard mass-spectrometry data. This innovative approach aims to uncover disease mechanisms and facilitate personalized treatment plans, ultimately improving patient care and affordability.

MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.

Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.

Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

Lidwave is a developer of advanced 3D sensing solutions aimed at transforming industries reliant on LiDAR technology. By introducing a novel three-dimensional sensing architecture, the company addresses significant limitations in traditional LiDAR and radar systems, particularly concerning bandwidth constraints. Its innovative Finite Coherence Ranging (FCR) technology delivers enhanced four-dimensional sensing capabilities, enabling precise Doppler and depth information. This breakthrough allows businesses to enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities, ultimately facilitating smarter and safer decision-making. Lidwave's approach not only resolves the challenges associated with existing sensing methods but also positions it as a leader in disruptive sensing technology.

Lavie Bio develops microbiome-based agricultural products, including bacterial compositions sprayed on plants, seed coatings, or soil amendments, to enhance crop performance. The portfolio includes bio-stimulants, bio-pesticides, biocontrol agents, and bio-inoculants derived from natural microbial sources to improve nutrient uptake and assimilation, enabling farmers to increase yield and crop quality. By harnessing beneficial microorganisms, Lavie Bio pursues sustainable alternatives to conventional inputs across diverse crops.

SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

TruLeaf Medical is a developer of user-friendly Transcatheter Mitral Valve Replacement (TMVR) solution.

IR-MED LTD. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company leverages advanced technologies, including big data and machine learning, to create innovative diagnostic modalities. IR-MED develops continuous and real-time monitoring devices capable of detecting and measuring various substances and pharmaceuticals in the blood. Additionally, their systems can assess fluid concentrations on surfaces and behind thin tissues, facilitating the identification and characterization of medical lesions and pathological processes in humans.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

TEClub VC is an investment firm for mega angels that invests in breakthrough technologies at early stages through a smart and selective investment platform. They focus on creating unicorn companies and venture creation models.

Eight Two Hundred Angels is an investment firm, They assist in promoting the companies in which they invest, attract investors, and qualify investors interested in investing in innovative technologies and high-risk investments.

Nugen Clean Energy specializes in off-grid electric vehicle (EV) charging systems. Their innovative technology uses a solid-state hydrogen compound to safely generate and utilize hydrogen on-site and on-demand, ensuring a reliable and sustainable power source even in remote locations. This enhances grid capacity and provides uninterrupted charging, making EV charging infrastructure more scalable and dependable.

AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.

Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

Sequentify develops innovative technology that combines synthetic biology and AI software tools for targeted DNA sequencing applications. These include cancer diagnostics, carrier screening, COVID-19 surveillance, and other genomic research areas.

FireDome's revolutionary wildfire defense system takes a two-tiered strategy. First, a mechanical launcher quickly deploys a protective barrier to impede the direct route of advancing wildfires. Second, the system actively detects and promptly extinguishes spot fires created by airborne embers that bypass the primary barrier.

Charging Robotics engages in wireless charging solutions.

NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.

CODA is a cloud-based AI platform that translates spoken language into sign language and provides the deaf community with easier access to video content in their preferred language.

Maris-Tech is a global leader in video and AI-based edge computing technology, pioneering intelligent video transmission solutions that conquer complex encoding-decoding challenges. Our miniature, lightweight, and low-power products deliver high-performance capabilities including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics. Founded by Israel technology sector veterans, Maris-Tech serves leading manufacturers worldwide in defense, aerospace, Intelligence gathering, homeland security (HLS) and communication industries worldwide. We’re pushing the boundaries of video transmission and edge computing, driving innovation in mission-critical applications across commercial and defense sectors.

Microbot Medical is a medical device company focused on transforming minimally invasive surgery through micro-robotic technologies. It develops systems and tools intended to enable precise navigation and manipulation within tubular lumens and vasculature, including the LIBERTY Endovascular Robotic System, designed as a single-use, remotely operated solution to improve precision, efficiency, and provider safety. The company is pursuing products such as the Self Cleaning Shunt for hydrocephalus and Normal Pressure Hydrocephalus, and TipCAT, a self-propelling, semi-disposable endoscope initially targeted at colonoscopy. Backed by a robust intellectual property portfolio consisting of issued patents and numerous patent applications, Microbot aims to broaden the reach of robotic assistance in endoluminal and endovascular procedures. The company was founded in 2010 and is headquartered in Hingham, Massachusetts.

Pashoot Robotics specializes in contextual robotics for manufacturing. It develops AI-Robotics software that enables robotic arms to learn and adapt to their environment, moving beyond pre-programmed tasks. This enhances production productivity and competitiveness.

SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

Oversight is a company that develops a 3D collaborative workspace platform aimed at enhancing decision-making for first responders. Its innovative platform integrates advanced artificial intelligence simulations and real-time data management from various devices, including drones, body cameras, and smartphones. This functionality allows emergency response teams to achieve comprehensive situational awareness, thereby improving mission planning and operational efficiency. By fusing diverse data sources into a single interactive environment, Oversight empowers clients to make informed decisions during critical situations, ultimately supporting their efforts in emergency response.

Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits, enabling physicians to assess complex cases swiftly. This improves patient wellness and enhances financial performance for providers and payers.

Founded in 2015, SuperMeat is an Israeli biotech and food-tech company that produces cultured meat from chicken cells in a controlled environment. This process reduces land use by 99% and water consumption by 90%, minimizing environmental impact while ensuring food safety without antibiotics.

VALFIX Medical is a Tel Aviv-based medical device company focused on transcatheter solutions for repairing and replacing the mitral and tricuspid valves, using multi-wire technology to provide a complete transcatheter repair and replacement approach, offering an alternative to open-heart surgery and addressing heart failure symptoms by eliminating mitral regurgitation.

Brevel develops innovative cultivation technology for sustainable, low-cost production of microalgae. Its high-tech, indoor, automated systems use internal illumination to achieve over 90% cost reduction and up to 200 times higher yields compared to traditional methods. Brevel targets various markets where microalgae-derived products are in demand.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.

Alumor develops solar-powered water purification technology devices based on ultraviolet LED light which can purify any type of surface water, including lakes, rivers, lagoons, and pools.

BeeHero develops a beehive technology platform that aims to increase crop yields by enhancing pollination. The platform combines artificial intelligence, machine learning, and in-hive sensors to collect data and optimize pollination during peak cycles, helping farmers protect hives from colony collapse and maximize pollination efficiency for growers worldwide. Founded in 2017, the company operates from Tel Aviv and Silicon Valley and focuses on providing data-driven insights and automation to support pollination across agricultural environments.

Kipp enables card issuers and merchants to approve more transactions, leading to higher customer satisfaction and greater revenue. Kipp's platform serves and supports issuer banks in optimizing their cards' business, leveraging their relationships with merchants, their willingness to share data and participate in the cost of risk.

IBI-Ag is a biotechnology company developing bioinsecticides using environmentally friendly technology. It focuses on discovering and developing selective, safe, and cost-effective biological solutions to control insects and increase crop production worldwide.

Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Spectalix empowers brands to reclaim and monetize their digital assets by integrating a unique white-label UGC platform. This platform enables users to engage with brand content using their mobile devices, creating personalized videos that can be shared on social media. Spectalix ensures brand safety through automated moderation.

Anicca is a mental health company focused on developing innovative technology for managing stress and emotional well-being. The company has created a wearable device that features a smart respiration sensor, which measures users' breathing patterns. This device also incorporates a tactile stimulation mechanism that delivers haptic feedback through pleasant vibrations synchronized with the user's breathing. By promoting better focus, improved sleep, and reduced anxiety, Anicca's product aims to provide users with an effective tool for on-the-go emotion and stress management.

Flytrex is the leading drone-based food delivery service in the United States, specializing in ultrafast deliveries from local restaurants to suburban areas. Operating in North Carolina and Texas, Flytrex has successfully delivered over 120,000 orders for its partners, including Little Caesars, Papa John's, and El Pollo Loco. The company's service is well-received by customers, with a monthly retention rate of 45% after two years, and an NPS score of 75%. Flytrex's drone delivery system significantly reduces delivery costs and times for its partners.

FertilAI is a healthcare company based in Israel that develops AI-driven technologies to enhance fertility treatments. Its platform, Fertilane, automates clinical decision-making processes for physicians and facilitates communication among clinics, doctors, and patients through tailored apps and web platforms.

Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

Baseline Vision is a developer of a cloud-based game analytics platform tailored for the net-sports market, with a primary focus on tennis. The company offers a scalable solution that utilizes a single portable smart-camera device to deliver real-time game analysis. This innovative technology unlocks a range of digital products, including line-calling, performance tracking, on-court gamification, and video feedback. Through its platform, Baseline Vision enables tennis players and coaches to review past training sessions, monitor their progress, connect with other players, and share content on social media. The integration of these features enhances the training experience and fosters a community among users.

DiA Imaging Analysis Ltd. is a technology company based in Beersheba, Israel, specializing in AI-powered ultrasound analysis designed to enhance the evaluation of cardiac function and other medical conditions. Founded in 2009, DiA offers a range of innovative applications, including LVivo EF for automated ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain, which assesses myocardial strain as an early indicator of reduced left ventricular function. Their tools simplify the ultrasound imaging process by providing automated analysis and optimal view selection, improving the diagnostic capabilities of clinicians. DiA's technology is compatible with various ultrasound devices and healthcare IT systems, streamlining the detection of clinical abnormalities. The company holds FDA and CE clearances and serves thousands of users globally, addressing critical challenges in ultrasound utilization by enabling more accurate and efficient image analysis through advanced pattern recognition and machine learning algorithms.

XRHealth Ltd. is a medical technology company based in Tel Aviv, Israel, that specializes in developing virtual reality (VR) software solutions for healthcare. Founded in 2016, the company offers an array of products designed to enhance patient care and treatment outcomes. Its offerings include VRPhysio, a platform for virtual physical therapy; VRReliever, which helps manage pain through distraction; VRCogni, aimed at improving motor function in stroke and dementia patients; and VRPsyc, which provides exposure therapy for various mental health disorders. Additionally, VRCoordi is designed to aid coordination recovery in patients with Parkinson's, brain injuries, and autism. By integrating immersive technologies with licensed clinicians and advanced data analytics, XRHealth provides comprehensive telehealth services, allowing patients to access treatment from the comfort of their own homes.

Cymptom is a cybersecurity company that offers a platform designed to protect organizations from cyber breaches by proactively assessing and visualizing potential attack paths. Utilizing agentless data collection technology, Cymptom maps critical risks to the MITRE ATT&CK® framework, enabling continuous monitoring of both on-premises and cloud environments. The platform identifies breach scenarios and pinpoints vulnerabilities without the need for attack simulations or interference with existing security measures. This approach allows organizations to receive real-time assessments of their security posture, prioritize mitigation strategies, and maintain operational continuity. By providing always-on cyber resilience, Cymptom supports business initiatives while minimizing the risk of cyber threats.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Nobio Ltd. is a biotechnology company based in Petah Tikva, Israel, specializing in the development of innovative nano-polymer additives that provide protection against microbial infections. Its technology enables the transformation of both implantable and non-implantable devices into biofilm-resistant platforms. Nobio's product offerings include a universal bonding agent designed for strong adhesion to various dental surfaces and restorative materials, as well as flowable composites suitable for dental restorations and sealants. The core of Nobio's technology consists of potent particles embedded with highly-active antimicrobial structures that kill bacteria upon contact, effectively preventing medical device contamination indefinitely. This unique approach positions Nobio as a leader in the creation of durable antimicrobial materials and surfaces, enhancing safety and efficacy in medical and dental applications.

BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.

Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

Brevel develops innovative cultivation technology for sustainable, low-cost production of microalgae. Its high-tech, indoor, automated systems use internal illumination to achieve over 90% cost reduction and up to 200 times higher yields compared to traditional methods. Brevel targets various markets where microalgae-derived products are in demand.

Anicca is a mental health company focused on developing innovative technology for managing stress and emotional well-being. The company has created a wearable device that features a smart respiration sensor, which measures users' breathing patterns. This device also incorporates a tactile stimulation mechanism that delivers haptic feedback through pleasant vibrations synchronized with the user's breathing. By promoting better focus, improved sleep, and reduced anxiety, Anicca's product aims to provide users with an effective tool for on-the-go emotion and stress management.

Sanolla is a digital healthcare company developing smart medical diagnosis solutions. Utilizing AI-powered detection and analysis of previously inaccessible body infrasounds, their affordable, non-invasive products enable immediate and accurate patient assessments, reducing clinic visits and lowering infection risks.

MedHub-AI develops deep-learning video analysis algorithms that provide diagnostic insights and practical guidance for physicians. Its algorithms can be integrated into medical video systems to support cardiology and gastroenterology diagnostics, processing large sets of clinical data, including visual and textual information. The company aims to improve decision-making and shorten procedure times by delivering a multilayered automated system from diagnosis through procedural guidance and documentation. Its solutions target cardiac catheterization and other diagnostic interventions, with the goal of reducing unnecessary invasive steps and improving health outcomes through image-based decision support.

Greeneye Technology develops AI-powered precision agriculture solutions that transform weed control by enabling real-time, selective herbicide spraying. Its proprietary selective spraying system turns standard sprayers into smart machines by detecting weeds and applying herbicides only where needed, reducing herbicide usage by up to 90%. Founded in 2017 and based in Tel Aviv, Israel, the company brings expertise across computer vision, artificial intelligence, agronomy, mechanical engineering, and spraying applications to help farmers implement sustainable, data-informed crop protection. The technology supports field insights and automated decision making to optimize spray applications, enabling farmers to lower chemical inputs while maintaining effective pest control.

RenalSense is a medical device company that develops real-time renal diagnostics and monitoring systems to detect changes in renal function and help prevent ICU-acquired acute kidney injury. Its flagship Clarity RMS system continuously measures urine flow and automatically transmits real-time data with alerts to medical staff, enabling early detection of deterioration in renal function. The company serves critical care settings and seeks to improve patient outcomes while reducing the cost of care. Founded in 2009, RenalSense is headquartered in Jerusalem and operates an office in Brookline, Massachusetts.

CathWorks is a medical technology company that applies computational science platforms to enhance percutaneous coronary intervention (PCI) therapy decisions. It offers CathWorks FFRangio, a non-invasive device delivering objective multi-vessel physiologic measurements to optimize and confirm intra-procedural PCI therapies.

Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Lineage Cell Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California, that specializes in the development and commercialization of innovative cellular therapies aimed at addressing unmet medical needs associated with degenerative diseases. The company’s leading product candidates include OpRegen, designed for the treatment of dry age-related macular degeneration, and OPC1, which targets acute spinal cord injuries. Additionally, Lineage is advancing VAC2, an allogeneic cancer immunotherapy aimed at non-small cell lung cancer. Other notable developments include Renevia, a hyaluronan-based hydrogel for treatment of HIV-associated facial lipoatrophy, and HyStem, a biomaterial for cell retention and delivery. Lineage also explores various therapeutic products for oncology and neurological disorders, alongside research programs focused on vision restoration and demyelination. Established in 1990, the company was formerly known as BioTime, Inc., and underwent a rebranding in August 2019.

OKO is a provider of crop micro-insurance services aimed at supporting farmers in emerging markets. The company leverages satellite information to assess risk and design tailored insurance products specifically for agricultural needs. By utilizing mobile technologies, OKO facilitates the distribution of insurance, collection of premiums, and management of claims. This innovative approach allows small farmers to access personalized and automated crop insurance policies at affordable rates, providing them with financial security against adverse weather conditions such as droughts and excessive rainfall.

Founded in 2017, Soapy Care manufactures IoT-powered hygiene micro-stations designed to provide users with a precise dose of soap and water. Their smart soap capsules ensure accurate dosing for hand-washing, promoting regulatory compliance and safety.

FARM INPUT & OUTPUT PRIVATE LIMITED operates a digital marketplace focused on agricultural produce in emerging markets, where internet access for farmers is limited. The company offers a hybrid platform that integrates both digital and SMS-based technologies, allowing farmers to list their crops through an AI-driven SMS chatbot. Buyers can search for available produce by location, time of sale, and quantity using the Farmster app or website. This innovative approach enables farmers to connect with potential buyers even before harvest, facilitating transactions and enhancing the agricultural value chain. By bridging the gap between farmers and buyers, FARM INPUT & OUTPUT PRIVATE LIMITED aims to improve market access and streamline the agricultural exchange process.

Criaterra manufactures sustainable building materials for eco-friendly construction. Utilizing natural resources and advanced manufacturing techniques, they produce recyclable wall tiles with thermal and acoustic insulation properties, aiming to reduce carbon emissions in the construction industry.

Spectalix empowers brands to reclaim and monetize their digital assets by integrating a unique white-label UGC platform. This platform enables users to engage with brand content using their mobile devices, creating personalized videos that can be shared on social media. Spectalix ensures brand safety through automated moderation.

The robotic smart kitchen revolution Profutech has developed a patent-protected robotic culinary “Smart Kitchen” device, preparing hot, fresh, and nutritious meals, with one automated click. The company is past the POC stage and addresses a market valued at billions.

Convizit is an AI-driven data-as-a-service company that automatically captures and enriches user interactions from websites and SaaS applications. It records events, attaches relevant properties, and delivers structured data to analytics tools, CDPs, and marketing platforms with minimal setup. The solution eliminates the need for manual tagging or code changes, enabling fast deployment and reliable, ready-for-action behavioral data for analytics, marketing, and personalization. The company is based in Tel Aviv, Israel.

Heurobotics researchers will further evolve the Mark II technology. “Heurobotics will be using the Agrowing company’s proprietary sensor technology to perform both remote and close sensing in the field to identify crop stress,” explained Kerry Karl, Heurobotics’ chief executive officer. “Agrowing’s team will work with Heurobotics engineers to develop optimal flight-profile requirements of a small unmanned aerial system of their configuration to collect meaningful data.”

MedAware develops innovative solutions using big data analytics and machine learning algorithms to analyze electronic medical records. Its patent-pending technology identifies and eliminates prescription errors in real-time, improving patient safety and reducing healthcare costs. Founded in 2012, MedAware is headquartered in Raanana, Israel.

Sanolla is a digital healthcare company developing smart medical diagnosis solutions. Utilizing AI-powered detection and analysis of previously inaccessible body infrasounds, their affordable, non-invasive products enable immediate and accurate patient assessments, reducing clinic visits and lowering infection risks.

Vectorious Medical Technologies Ltd. is a medical device company based in Tel Aviv, Israel, specializing in innovative solutions for patients with congestive heart failure. Founded in 2011, the company has developed the V-LAP, the first in-heart microcomputer designed to enhance treatment for heart failure patients by facilitating daily monitoring of left atrial pressure (LAP). This miniature wireless implant is a groundbreaking device that operates without batteries and can transmit data from deep within the body, offering a reliable means of detecting potential deterioration in heart failure. The V-LAP has been recognized as an effective predictor of heart failure worsening, thereby improving patients' quality of life and life expectancy. Vectorious is currently conducting clinical studies in various European countries, including Italy, Germany, and the UK, to obtain regulatory approval, with plans to initiate a clinical study in the United States.

LahakX is an agricultural technology company specializing in autonomous drone solutions for crop protection. It offers growers the ability to utilize a self-flying fleet of spraying drones, which can be deployed at the push of a button, allowing for efficient and precise application of agricultural chemicals. The company's proprietary technology enables both uniform coverage and targeted spot spraying, significantly reducing chemical usage while improving safety and productivity. LahakX's system not only minimizes labor and operational costs but also enhances the overall efficiency of farming practices. Growers can opt to purchase the complete spraying solution or engage LahakX to provide spraying services directly. Having launched its operations in the United States earlier this year, LahakX is positioned to deliver sustainable and innovative solutions to modern agricultural challenges.

Talenya Ltd is a technology-driven company that specializes in talent sourcing solutions. Founded in 2016 and headquartered in Rosh Haayin, Israel, with an additional office in Hoboken, New Jersey, Talenya utilizes artificial intelligence and machine learning to streamline the recruitment process. Its platform employs advanced algorithms to identify potential candidates by collecting and analyzing data from various online sources. This enables the platform to match candidate profiles with job openings effectively. Talenya's solution not only automates the talent sourcing process but also assesses and validates leads, presenting employers with qualified and diverse candidates. By empowering talent experts to establish their own recruitment practices, Talenya facilitates immediate access to both employers and suitable candidates.

Microbot Medical is a medical device company focused on transforming minimally invasive surgery through micro-robotic technologies. It develops systems and tools intended to enable precise navigation and manipulation within tubular lumens and vasculature, including the LIBERTY Endovascular Robotic System, designed as a single-use, remotely operated solution to improve precision, efficiency, and provider safety. The company is pursuing products such as the Self Cleaning Shunt for hydrocephalus and Normal Pressure Hydrocephalus, and TipCAT, a self-propelling, semi-disposable endoscope initially targeted at colonoscopy. Backed by a robust intellectual property portfolio consisting of issued patents and numerous patent applications, Microbot aims to broaden the reach of robotic assistance in endoluminal and endovascular procedures. The company was founded in 2010 and is headquartered in Hingham, Massachusetts.

SoftWheel is a technology company based in Tel Aviv, Israel, that specializes in developing advanced in-wheel suspension systems. Founded in 2011, the company focuses on enhancing personal mobility by creating innovative suspension solutions for wheelchairs, bicycles, and automobiles. SoftWheel's products include suspension arms and wheel rims, which are designed to absorb shocks and vibrations while providing rigidity and stability. The company operates through a network of resellers both domestically in Israel and internationally. It has established strategic partnerships with leading global companies such as NSK and Linamar to drive sustainable transportation and improve people’s lives through innovative technology.

Yarok Microbio is a company that specializes in advanced microbiological testing technology for the agriculture and food supply sectors. It has developed a system that significantly accelerates the detection of harmful microbes, including E. coli, Listeria, and Salmonella, providing results in just 45 minutes compared to the days required by traditional methods. This rapid testing capability addresses critical needs in the AgriFood industry, helping producers avoid costly product recalls, lawsuits, and ensuring consumer safety. The technology is versatile, applicable across various food categories, and also offers early detection of plant pathogens, which aids in the timely implementation of phytosanitary measures and reduces pesticide use. Yarok's research and development laboratory is based in Jerusalem, Israel, with a demonstration lab in Milan, Italy, to support marketing efforts in Europe. The company has received recognition for its innovative approach, including the UNIDO Innovation Award in 2017 and being named one of the Top Five Disruptors in the food technology sector by the Institute of Food Technologists in 2019.

City Transformer is an automotive technology company focused on creating innovative solutions for urban mobility. The company has developed an electric city vehicle featuring a patented folding mechanism that allows the car to narrow to just one meter in width. This unique design enables drivers to easily navigate tight traffic and park in spaces typically reserved for motorcycles, significantly enhancing urban parking convenience. The vehicle combines advanced technology, including smart sensors, while prioritizing safety and an improved driving experience. By adapting the car's dimensions and driving behavior, City Transformer addresses the challenges of conventional passenger vehicles, making urban commuting more efficient and accessible.

Lineage Cell Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California, that specializes in the development and commercialization of innovative cellular therapies aimed at addressing unmet medical needs associated with degenerative diseases. The company’s leading product candidates include OpRegen, designed for the treatment of dry age-related macular degeneration, and OPC1, which targets acute spinal cord injuries. Additionally, Lineage is advancing VAC2, an allogeneic cancer immunotherapy aimed at non-small cell lung cancer. Other notable developments include Renevia, a hyaluronan-based hydrogel for treatment of HIV-associated facial lipoatrophy, and HyStem, a biomaterial for cell retention and delivery. Lineage also explores various therapeutic products for oncology and neurological disorders, alongside research programs focused on vision restoration and demyelination. Established in 1990, the company was formerly known as BioTime, Inc., and underwent a rebranding in August 2019.

Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.

BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.

VBL Therapeutics is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases. The company utilizes two proprietary platform technologies that harness the body's natural physiological and genetic regulatory elements. Its lead product candidate, VB-111, is a gene-based biologic aimed at treating solid tumors, specifically recurrent glioblastoma, an aggressive form of brain cancer. In addition to its oncology efforts, VBL Therapeutics is pursuing programs that target anti-inflammatory diseases, leveraging its Lecinoxoid platform technology. The company's diverse portfolio reflects its commitment to advancing innovative therapeutic solutions in the biopharmaceutical landscape.

CYREN Ltd. is a cybersecurity company that specializes in providing cloud-based information security solutions for web, email, and mobile transactions. Founded in 1991 and headquartered in McLean, Virginia, CYREN offers a range of services through its Cyren Cloud Security platform, including Web Security, DNS Security, Email Security, and Cloud Sandboxing, all designed to protect businesses from various cyber threats. The company also provides Cyren Threat Intelligence Services, which include APIs and SDKs for cyber threat detection, as well as advanced endpoint security solutions to combat malware and ransomware. CYREN's global network processes 17 billion transactions daily, safeguarding approximately 600 million users around the world. The company's products are marketed through direct and indirect channels, including value-added resellers and managed service providers, primarily serving enterprise customers and original equipment manufacturers.

TripleW is a company that specializes in upcycling food waste into lactic acid, a critical component for producing PLA bioplastics. By utilizing organic waste as feedstock, TripleW's innovative bioprocess technology allows for the conversion of waste materials into valuable building blocks for bioplastic production. This process not only reduces production costs for clients but also contributes to environmental sustainability by decreasing reliance on traditional food crops for lactic acid. As the demand for lactic acid is projected to grow significantly in the coming years, TripleW's approach aims to decarbonize waste on a large scale by recycling PLA food and beverage packaging waste back into the production cycle.

AbiliSense Ltd., established in 2015 and headquartered in Tel Aviv-Yafo, Israel, specializes in developing sound recognition technology. The company's core product enables IoT devices to continuously monitor environmental sounds, providing real-time alerts for potential hazards or anomalies to applications, emergency call-centers, or smart devices. This innovation aims to enhance safety and security by empowering IoT devices with AI-driven smart listening capabilities.

Sanolla is a digital healthcare company developing smart medical diagnosis solutions. Utilizing AI-powered detection and analysis of previously inaccessible body infrasounds, their affordable, non-invasive products enable immediate and accurate patient assessments, reducing clinic visits and lowering infection risks.

Founded in 2019, Flyworks develops innovative hybrid propulsion drones. Their patent-pending technology combines internal combustion engine power for extended flight duration with electric drive for maneuvering, enabling significant payload capacity while maintaining safety and cost-efficiency.

Since 2012 Reduxio has redefined data management and data protection, and the company has evolved its mission to deliver the first microservices-based storage and data platform for stateful applications. Reduxio’s cloud data platform for Kubernetes pairs high performance software-defined container-native storage and data management with data mobility to enable customers to build a single data cloud for their applications across all their infrastructure, anywhere. Reduxio is backed by Intel Capital, C5 Capital Cloud Partners and Jerusalem Venture Partners (JVP).

TuneFork is a company specializing in audio personalization technology software aimed at delivering an optimal hearing experience across various devices. The software guides users through a clinically accurate self-test to create a personalized Audio Profile, which characterizes individual hearing capabilities. This profile is then used to tailor precise audio filters, ensuring the best possible match between the user's sound system and their unique hearing characteristics. TuneFork can be integrated into any operating or network system to optimize all types of audio content, including phone calls, music, video, voice messages, and alerts. The technology is particularly beneficial for smartphones, which are widely used for communication, entertainment, and social networking. By enhancing the audio experience, TuneFork not only improves sound quality but also helps mitigate potential hearing damage from unbalanced audio.

Amplio is the first and only Impact Platform for Special Education. We are on a mission to help students with special learning needs reach their full potential. The Amplio Platform including research and evidence-based curricula and programs is designed to deliver intensive, rigorous instruction to prepare students for success, both academically and in their everyday lives. Our solutions are developed in conjunction with parents and a world- class advisory council, academics, and school administrators with expertise in special populations. Tens of thousands of students have received services and interventions using the Amplio platform since the solution was launched in 2019.

Lineage Cell Therapeutics is a clinical-stage biotechnology company headquartered in Carlsbad, California, that specializes in the development and commercialization of innovative cellular therapies aimed at addressing unmet medical needs associated with degenerative diseases. The company’s leading product candidates include OpRegen, designed for the treatment of dry age-related macular degeneration, and OPC1, which targets acute spinal cord injuries. Additionally, Lineage is advancing VAC2, an allogeneic cancer immunotherapy aimed at non-small cell lung cancer. Other notable developments include Renevia, a hyaluronan-based hydrogel for treatment of HIV-associated facial lipoatrophy, and HyStem, a biomaterial for cell retention and delivery. Lineage also explores various therapeutic products for oncology and neurological disorders, alongside research programs focused on vision restoration and demyelination. Established in 1990, the company was formerly known as BioTime, Inc., and underwent a rebranding in August 2019.

Gamida Cell Ltd., established in 1998 and headquartered in Jerusalem, Israel, is a clinical-stage biopharmaceutical company focused on developing advanced cell therapies to treat blood cancers and serious blood diseases. The company's lead product candidate, omidubicel, is an expanded hematopoietic stem cell therapy derived from umbilical cord blood, currently in Phase 3 studies for patients with high-risk hematologic malignancies and severe aplastic anemia. Additionally, Gamida Cell is developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase 1/2 trials for relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Both candidates leverage the company's proprietary expansion platform based on nicotinamide to enhance cell properties and therapeutic potential.

Nanofabrica is a pioneering company based in Tel Aviv, Israel, specializing in 3D printing technology for precision manufacturing. Founded in 2016, the company focuses on micro and nanomanufacturing, offering solutions for various sectors, including semiconductors, optics, and medical devices. Its innovative Micro Adaptive Projection technology enables the production of ultra-precise and complex parts with an unprecedented micron-resolution. This capability allows for rapid manufacturing of high-performance components, significantly reducing costs and time compared to traditional methods. By integrating advanced optics and semiconductor lithography with 3D printing, Nanofabrica serves mass customization needs, responding to customer feedback to continuously refine its technology and expand into new markets such as robotics and biomedical applications.

odix is a cybersecurity company that specializes in developing advanced anti-malware tools utilizing Content Disarm and Reconstruction (CDR) technology. Its innovative platform is designed to prevent file-based cyber-attacks across enterprises of all sizes by effectively disarming malicious code embedded within commonly used file types. By employing unique deep file analysis techniques and patented algorithms, odix ensures that unknown malware, often hidden in seemingly benign files, is neutralized before it can infiltrate organizational networks. This proactive approach positions odix as a key player in the field of preventative cybersecurity, offering clients robust malware prevention services tailored to meet their specific needs.

Oxitone Medical is a medical device company that has developed a wrist-based pulse oximetry continuous monitoring platform for home care and remote patient management. The FDA-cleared solution uses AI-assisted analytics to turn continuous data into personalized therapeutic guidance without requiring a fingertip probe, enabling efficient remote monitoring of high-risk patients. The system is deployed in more than ten countries and supports continuous data collection for hyper-personalized interventions, with partnerships including Ascom for monitoring COVID-19 patients.

CardiacSense Ltd., founded in 2012 and based in Caesarea, Israel, develops innovative medical wearable devices aimed at monitoring heart arrhythmias and other critical health metrics. The company's FDA and CE certified medical watches and wristbands provide continuous, long-term, ambulatory, and non-invasive monitoring of vital functions, including heart rate, pulse rate, respiratory rate, core temperature, oxygen saturation, and blood pressure. Utilizing advanced PPG technology, CardiacSense's devices enable accurate real-time diagnostics for various medical conditions such as atrial fibrillation, hypertension, chronic obstructive pulmonary disease, heart failure, sleep apnea, and infections like COVID-19. By focusing on the prevention and early detection of cardiac events, CardiacSense aims to enhance healthcare delivery and improve patient outcomes.